• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

MIS

Anonymous board for MIS
Replies
2
Views
3K
anonymous
Replies
13
Views
5K
anonymous
Replies
17
Views
18K
anonymous
Replies
1
Views
2K
Anonymous
Replies
5
Views
6K
Anonymous